Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial

BACKGROUND: The PD COMM pilot randomised controlled trial compared Lee Silverman Voice Treatment (LSVT® LOUD) with standard NHS speech and language therapy (SLT) and a control arm in people with Parkinson’s disease (PwPD) with self-reported problems with voice or speech. This analysis compares costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Scobie, Sarah, Jowett, Sue, Lambe, Tosin, Patel, Smitaa, Woolley, Rebecca, Ives, Natalie, Rick, Caroline, Smith, Christina, Brady, Marion C, Clarke, Carl, Sackley, Cath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351093/
https://www.ncbi.nlm.nih.gov/pubmed/34372913
http://dx.doi.org/10.1186/s40814-021-00888-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351093/
https://www.ncbi.nlm.nih.gov/pubmed/34372913
http://dx.doi.org/10.1186/s40814-021-00888-y

Ejemplares similares